SNCA and Parkinson disease: Furthermore, the buildup of 3, 4-dihydroxyphenylacetaldehyde (DOPAL) in the brains of Parkinson's disease patients not only degrades synaptic vesicles, but also induces an accumulation of α-synuclein in the terminals of nerves [19].